Dr. Hanna Viisanen-Kuopila received her PhD degree in Physiology in 2012, at the Faculty of Medicine, University of Helsinki. Dr. Viisanen-Kuopila worked with Prof. A. Pertovaara in the Department of Physiology and used electrophysiological and behavioral approaches to study plasticity in pain modulatory pathways in pre-clinical models of chronic pain. Her doctoral thesis concentrated on the characterization of the M1 stimulation-induced antinociceptive effects, and whether that descending antinociception was relayed through the noradrenergic, serotonergic or dopaminergic pathways. She was a visiting scientist in the laboratory of Prof H.G. Schaible in the Friedrich-Schiller-University Jena, Germany during 2009-2010.
During her post-doctoral period in Department of Physiology, University of Helsinki (2012-2014) she studied the involvement of the transient receptor potential ankyrin (TRPA1) ion channel in the pathophysiology of peripheral diabetic neuropathy. Dr. Viisanen-Kuopila has authored or co-authored 12 peer-reviewed publications. She joined the group of Prof. E. Kalso and Dr. P. Rauhala in 2015 to study pharmacology in pre-clinical models of pain, and to study opioid pharmacology and tolerance.
In GLORIA, Dr. Viisanen-Kuopila is involved in characterization of novel GLORIA compounds in pre-clinical models of pain.
University of Helsinki: Mikko Airavaara • Viljami Jokinen • Eija Kalso • Oleg Kambur • Leena Karhinen • Mari Kaunisto • Tuomas Lilius • Vânia Moreira • Kert Mätlik • Pekka Rauhala • Mart Saarma • Yulia Sidorova • Ilida Sulemanyova • Li Tian • Jaakko Vartia • Hanna Viisanen-Kuopila • Henri Xhaard • Jari Yli-Kauhaluoma